• About us
• Contact

Advertisement

Person › Details

Laurent Lévy (Nanobiotix S.A. (Euronext Paris: NANO, Nasdaq: NBTX))

Lévy, Laurent (NanoBiotix 201103 CEO)

 

	Organisation	Nanobiotix S.A. (Euronext Paris: NANO, Nasdaq: NBTX)
	Group	Nanobiotix (Group)
	Product	nanobiotechnology
	Product 2	oncology

Record changed: 2023-07-24

Advertisement

More documents for Laurent Lévy

• [1] Nanobiotix S.A.. (7/10/23). "Press Release: Nanobiotix Announces License Agreement for Worldwide Co-development and Commercialization of Potential First-In-Class Radioenhancer NBTXR3". Paris & Cambridge, MA....
• [2] Nanobiotix S.A.. (5/28/19). "Press Release: Nanobiotix Announces the Launch of Curadigm. A New Nanotechnology Platform for Healthcare". Paris & Cambridge, MA....
• [3] Nanobiotix S.A.. (4/4/19). "Press Release: Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval". Paris & Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.